Abstract: Charging systems and methods are provided, which increase charging currents and reduce charging durations for battery cells with metalloid-based anodes that enable high C-rate (charging rate) charging. Specifically, methods comprise charging battery cells having metalloid-based anodes having Si, Ge and/or Sn-based anode active material, by providing a high-C charging current of at least 4 C (or 5 C, or 10 C or more) over a range of at least 10-70% SoC (state of charge) of the battery cells. Charging systems comprise a booster unit configured to provide a high-C charging current over at least most of the SoC range of battery cells having metalloid-based anodes in the at least one battery unit. Charging systems further comprise a user interface configured to receive user preferences concerning a specified charging duration and/or a specified target SoC—for implementation by the charging system.

Abstract: The present invention provides a method to identify and use compounds for the inhibition of abnormal or dysregulated hepatic glucose production that results in elevated blood glucose levels and associated metabolic disorders. The invention is based on the surprising discovery that the glucagon forms an obligate binding complex with aP2, which is necessary for activation of the glucagon G-coupled protein receptor.

Abstract: Charging systems and methods are provided, which increase charging currents and reduce charging durations for battery cells with metalloid-based anodes that enable high C-rate (charging rate) charging. Specifically, methods comprise charging battery cells having metalloid-based anodes having Si, Ge and/or Sn-based anode active material, by providing a high-C charging current of at least 4 C (or 5 C, or 10 C or more) over a range of at least 10-70% SoC (state of charge) of the battery cells. Charging systems comprise a booster unit configured to provide a high-C charging current over at least most of the SoC range of battery cells having metalloid-based anodes in the at least one battery unit. Charging systems further comprise a user interface configured to receive user preferences concerning a specified charging duration and/or a specified target SoC—for implementation by the charging system.

Abstract: The present invention provides a method to identify and use compounds for the inhibition of abnormal or dysregulated hepatic glucose production that results in elevated blood glucose levels and associated metabolic disorders. The invention is based on the surprising discovery that the glucagon forms an obligate binding complex with aP2, which is necessary for activation of the glucagon G-coupled protein receptor.

Abstract: A pocket-size computer peripheral system includes a computer peripheral device made up of at least two separable portions and an attachment bracket. The attachment bracket forms a sliding interconnection between the system and pocketable personal articles. Additionally, or alternatively, the attachment bracket selectively assumes one of two different attachment states with the separable portions of the device.